Company announced the publication of clinical data from a Phase 1/2 trial of TG-1101 (ublituximab), the Company’s novel glycoengineered anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkins Lymphoma (NHL) or Chrionic Lymphocytic Leukemia (CLL) previously exposed to rituximab. The data demonstrates single agent TG-1101 to be well tolerated with the most common adverse event observed […]
Microblogs
January 30, 2017
AUPH: Acquiring more shares of AUPH
To All, Just looking for some feedback from everyone. I was considering purchasing more Aurinia to possibly take advantage of the short term catalyst which would be the upcoming release of secondary data from their Phase IIb Aura trial to help recoup losses from the FDA debacle of RGLS. Maybe some have already done so. […]
January 13, 2017
Tg Therapeutics
To All, I noticed that Michael Weiss, CEO of TG Therapeutics reduced his total share count considerably in 2016. He went from owning 4.5 million shares down to 1.1 million. Maybe he had to unload them by a certain date, I am not that familiar with shares owned by insiders. Just wanted to bring it […]
Take TG Therapeutics as an example, it has gone from 9.57 to 5.89 in a matter of 5,6,7 trading days scaring or forcing novice investors out of a position that will eventually recover.
Recent Author Comments
Posted on September 20, 2018
Posted on March 4, 2018
Cleveland, Someone on this site commented about a conference call yesterday, I don't know if it is true or not. I tried calling the old replay number but it asked for a access code, never asked for one before, I don't have it so I was denied access to the [...]
Posted on February 7, 2018
Thomas, Great piece on cancer research, is there a publicly traded company that we could invest in using this approach?[...]
Posted on January 24, 2018
VTGN,Pgathua, Excellent article reagrding Vistagen but I have a question maybe you can help me with, is the patent for the "mechanism of action". I am not a scholar by any means but does this cover the way AV-101 is manufactured and does it cover the age[...]
Posted on January 18, 2018
SNDXTo All, In the last 30 minutes or so, Syndax has gone up from 9.20ish to 9.80 or so and volume hs increased dramatically!![...]
Posted on January 17, 2018
fanfare, knowledge is power[...]
Posted on January 9, 2018
Hey Doc, DFFN- I was reviewing the members on the Scientific Advisory Board of Diffusion Pharna and it is like a list of Who's Who. Their credentials are just staggering. With the wealth of knowledge and experience that these gentlemen have, how do you go [...]
Posted on December 27, 2017
kirzli, sndx-I share your concern, but I hope that entinostat will have better results with advanced hormone receptor positive breast cancer. I am buried in the stock and I am going to stick it out.[...]
Posted on December 27, 2017
Doc Apto-I also saw that document on Friday as well, and I thought the same, it was unclear.[...]
Posted on December 22, 2017
SoGi, APTO ow as well- The bid is 1.87 and the ask is 1.95. Thde bid is .12 cents higher in premarket now. I utilize etrade, for some reason they asre always behind the news. I should have held the massive amount of shares I had. Best of luck to all of us.[...]
Posted on December 20, 2017
SoGiAm, Thanks for passing on the article by Dr. Gottlieb. It appears to me that gene therapy may be a hot topic in 2018 and beyond. Just curious, are there any gene therapy companies that you like or possibly have the potential of success. Maybe gene ther[...]
Posted on December 14, 2017
BABY, More like 40%-45%[...]
Posted on December 6, 2017
Doc, VTGN You had mentioned on the conference call on Friday that in your opinion, Vistagen had been unfairly punished by the market. What happened to Vistagen that the marekt punished them for. I dont remember if you had given us the reason why, if there[...]
Posted on November 20, 2017
To All, APTO Greg Chow and Dr. Rice have treated me like I am an institutional investor and made me feel welcomed and respected, you can't put a price on that and they have my full support regardless of the outcome. As I mentioned in an earlier post, Dr. R[...]
Posted on November 20, 2017
zimmy,, In my opinion, if you don't see dilution, due to the fact that dilution goes hand in hand with raising capital, is more of an issue than not. And also, the amount of shares that are currently available for Aptose are only 20 million plus which is s[...]
Posted on November 17, 2017
Doc, Dr. Rice is the only CEO to ever personally respond to one of my questions, that goes along with way with me and both Greg and Dr. Rice have my full support. Doc, those guys are good people and thanks again for the recommendation. I have no doubt that[...]
Posted on November 16, 2017
mmccrum, Everyone here praises Dr. KSS and rightfully so, but we hardly ever thank Cleveland for what he brings to the table, which in my opinion, is just as important as the science. Look what happened to Windtree due to their mishandling of funds. Thank [...]
Posted on November 7, 2017
ARTH Exactly Tanglewood, seen it to many times, puch the stock down 20-30% then shortly after news is released[...]
Posted on November 7, 2017
ARTH, I was watching the activity on ARTH, they pushed the price of the shares down to the 50 cent range and scooped up over 200,000 shares and then it went back up to 55 cents on the ask all within 10 seconds, UNBELIEVABLE. Either 1 of two things 1) short[...]
Posted on November 7, 2017
ARTH What takes so long for the FDA to respond to their NDA, they did submit one.[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
Travis, I stuck with you!!!! Travis, I remember seeing a substantial list of investments which could have been be your portfolio or just a list of equities with a better chance to appreciate. Would you mind sharing that list again and if it is displayed s[...]